Non-small cell lung cancer: Clinical value of new biological predictors

被引：61
作者：
Graziano, SL [1 ]
机构：
[1] SUNY HLTH SCI CTR, SYRACUSE, NY 13210 USA
来源：
LUNG CANCER | 1997年 / 17卷
关键词：
lung cancer; non-small cell lung cancer; prognosis;
D O I：
10.1016/S0169-5002(97)00639-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S37 / S58
页数：22
相关论文
共 131 条
[1]   THE NEU ONCOGENE ENCODES AN EPIDERMAL GROWTH-FACTOR RECEPTOR-RELATED PROTEIN [J].
BARGMANN, CI ;
HUNG, MC ;
WEINBERG, RA .
NATURE, 1986, 319 (6050) :226-230
[2]  
BODNER SM, 1992, ONCOGENE, V7, P743
[3]  
BOS JL, 1989, CANCER RES, V49, P4682
[4]  
BULZEBRUCK H, 1992, CANCER-AM CANCER SOC, V70, P1102, DOI 10.1002/1097-0142(19920901)70:5<1102::AID-CNCR2820700514>3.0.CO
[5]  
2-5
[6]   P53 IMMUNOSTAINING POSITIVITY IS ASSOCIATED WITH REDUCED SURVIVAL AND IS IMPERFECTLY CORRELATED WITH GENE-MUTATIONS IN RESECTED NONSMALL CELL LUNG-CANCER - A PRELIMINARY-REPORT OF LCSG-871 [J].
CARBONE, DP ;
MITSUDOMI, T ;
CHIBA, I ;
PIANTADOSI, S ;
RUSCH, V ;
NOWAK, JA ;
MCINTIRE, D ;
SLAMON, D ;
GAZDAR, A ;
MINNA, J .
CHEST, 1994, 106 (06) :S377-S381
[7]   IMPLICATIONS OF THE P53 TUMOR-SUPPRESSOR GENE IN CLINICAL ONCOLOGY [J].
CHANG, FJ ;
SYRJANEN, S ;
SYRJANEN, K .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (04) :1009-1022
[8]  
CHIBA I, 1990, ONCOGENE, V5, P1603
[9]  
CIBAS ES, 1989, CANCER, V63, P1552, DOI 10.1002/1097-0142(19890415)63:8<1552::AID-CNCR2820630817>3.0.CO
[10]  
2-F
12345678910